More Jenburkt Pharmaceuticals Ltd news
Jenburkt Pharmaceuticals LtdBSE: JENBURPH

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

Oct 12, 2026 at 8:11 AM EDT · Issued by Jenburkt Pharmaceuticals Ltd via BSE India

Filed with BSE · ISIN INE354A01013 · Oct 12, 2026 at 8:11 AM EDT · 5 pages · English

On 6ix: 6ix.com/news/disclosures-under-reg-291-of-sebi-sast-regulations-2011-22

Jenburkt Pharmaceuticals Ltd on 6ix

Earlier from Jenburkt Pharmaceuticals

  • Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 12
  • Jenburkt Pharmaceuticals Ltd Press Release Sep 04 2026Sep 4
  • Jenburkt Pharmaceuticals Ltd Press Release Aug 07 2026Aug 7
  • Jenburkt Pharmaceuticals Ltd Press Release Aug 04 2026Aug 4
  • Jenburkt Pharmaceuticals Ltd Press Release Aug 03 2026Aug 3

Later from Jenburkt Pharmaceuticals

  • Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2026.Oct 29
  • Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 4
  • Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Nov 4
All Jenburkt Pharmaceuticals news releases↗

Follow Jenburkt Pharmaceuticals into a list and get an email when it puts out news.

Follow Jenburkt Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer